The small molecule 6DBF7 is a dibenzofuran (DBF)-based peptidomimetic of Gal-1, whose galectin inhibitor activity was shown as it inhibited tumor angiogenesis and tumor growth in mouse cancer models such as melanoma, lung, and ovarian cancer[137]. Here, LGALS1 is linked to melanoma.